Jump to content
  • AI independently developed a new flu vaccine


    In its development, humanity is rapidly approaching the point where all the work for him will do artificial intelligence. It sounds fantastic, but this future is much closer than it seems. Confirmation of these words are the latest achievements of AI, developed by a team of scientists from the University of Flinders. He created the flu vaccine. himself.

    AI independently developed a new flu vaccine

    Of course, this is not the first time that AI has served medicine. Previously, robots and surgical operations were performed, and the disease was diagnosed, and in the creation of drugs helped. But before artificial intelligence could invent their own vaccine, it did not reach. Till recently. Australian researchers have created an AI program, which is an algorithm to search for ligands, and put it in a pair with his other development — "synthetic chemist", generating trillions of different compounds. The second "fed" data to the first, which, in turn, selected drugs that can interact with the human immune system as a vaccine against influenza.

    The experiment was successful — AI was able to withdraw the vaccine from a common disease. Scientists synthesized the proposed program composition and tested it in the laboratory. First on human cell culture, and then on animals. So how good is the vaccine? According to the researchers, almost perfect.

    AI independently developed a new flu vaccine

    Quote

    "During the study, it became clear that the vaccine works. It has the highest degree of protection of the body against influenza, far surpassing in this parameter all currently existing vaccines. It remains only to confirm the results in humans," said Professor Nikolai Petrovsky, the lead author of the study.

    Precise data about when scientists undertake the verification of the vaccine on humans yet. But most likely, it will happen very soon: the researchers received a grant to conduct experiments from the National Institute of Allergy and infectious diseases of the United States. They have already begun preparations for a 12-month trial of a promising drug.


    User Feedback

    Recommended Comments

    There are no comments to display.



    Guest
    Add a comment...

    ×   Pasted as rich text.   Paste as plain text instead

      Only 75 emoji are allowed.

    ×   Your link has been automatically embedded.   Display as a link instead

    ×   Your previous content has been restored.   Clear editor

    ×   You cannot paste images directly. Upload or insert images from URL.

    Loading...

×
×
  • Create New...

Important Information

We have placed cookies on your device to help make this website better. You can adjust your cookie settings, otherwise we'll assume you're okay to continue.